NMR (Nomura Holdings, Inc)

Insider Trading Activity

Every open-market purchase and sale reported by NMR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
0
code S
Reporting Insiders
19
current holders
NMR — Recent Form 4 Transactions (latest 2026-07-27)
FiledInsiderRole TypeSharesValue
2026-07-27 Yukiko Ozaki See Remarks A
2026-07-27 Shoji Ogawa Director A
2026-07-27 Akio Hori See Remarks A
2026-07-27 Hiroyasu Koike See Remarks A
2026-07-27 Masahiro Ishizuka Director A
2026-07-27 Akihito Tobari See Remarks A
2026-06-29 Yukiko Ozaki See Remarks A
2026-06-29 Koji Nagai Director A
2026-06-29 Akio Hori See Remarks A
2026-06-29 Hiroyasu Koike See Remarks A
2026-06-29 Akihito Tobari See Remarks A
2026-06-29 Masahiro Ishizuka Director A
2026-06-29 Shoji Ogawa Director A
2026-05-27 Takako Mori See Remarks A
2026-05-27 Naotaka Minami See Remarks A
2026-05-27 Akio Hori See Remarks A
2026-05-27 Akihito Tobari See Remarks A
2026-05-27 Sotaro Kato See Remarks A
2026-05-27 Shoji Ogawa Director A
2026-05-27 Masahiro Ishizuka Director A
2026-05-27 Christopher Paul Willcox See Remarks A
2026-05-27 Masahiro Goto See Remarks A
2026-05-27 Takumi Kitamura See Remarks A
2026-05-27 Kentaro Okuda See Remarks A
2026-05-27 Yuko Horiuchi See Remarks A
2026-05-27 Toshiyasu Iiyama See Remarks A
2026-05-27 Go Sugiyama See Remarks A
2026-05-27 Yutaka Nakajima See Remarks A
2026-05-27 Hiroyuki Moriuchi See Remarks A
2026-05-27 Yukiko Ozaki See Remarks A
2026-05-27 Hiroyasu Koike See Remarks A
2026-05-27 Koji Nagai Director A
2026-04-28 Shoji Ogawa Director A
2026-04-28 Masahiro Ishizuka Director A
2026-04-28 Naotaka Minami See Remarks MIXED
2026-04-28 Akihito Tobari See Remarks MIXED
2026-04-28 Go Sugiyama See Remarks MIXED
2026-04-28 Takako Mori See Remarks MIXED
2026-04-28 Hiroyuki Moriuchi See Remarks MIXED
2026-04-28 Toshiyasu Iiyama See Remarks MIXED
2026-04-28 Yutaka Nakajima See Remarks MIXED
2026-04-28 Yuko Horiuchi See Remarks MIXED
2026-04-28 Kentaro Okuda See Remarks MIXED
2026-04-28 Sotaro Kato See Remarks MIXED
2026-04-28 Hiroyasu Koike See Remarks MIXED
2026-04-28 Koji Nagai Director MIXED
2026-04-28 Masahiro Goto See Remarks MIXED
2026-04-28 Takumi Kitamura See Remarks MIXED
2026-04-28 Christopher Paul Willcox See Remarks MIXED
2026-04-28 Yukiko Ozaki See Remarks MIXED
NMR — Current Insider Holders
InsiderRole Shares HeldValue
See Remarks 682,743
See Remarks 529,192
Director 512,942
See Remarks 301,656
See Remarks 243,374
See Remarks 145,534
See Remarks 114,637
See Remarks 106,033
See Remarks 62,774
See Remarks 60,233
Director 59,262
See Remarks 53,814
See Remarks 30,676
See Remarks 29,078
See Remarks 22,925
See Remarks 21,087
See Remarks 18,448
See Remarks 14,586
Director 11,082
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the NMR quote page; the site-wide leaderboard is on the insider transactions hub.